Synthesis and purification of site-specifically modified T7 RNA polymerase for bioorthogonal conjugation applications

Authors

  • D. O. Semeniuk Yuria-Pharm LLC 19, Sviatoslava Khorobroho Str., Kyiv, Ukraine, 03161 Author
  • N. O. Hrubiian Yuria-Pharm LLC 19, Sviatoslava Khorobroho Str., Kyiv, Ukraine, 03161 Author
  • S. O. Novosolov Yuria-Pharm LLC 19, Sviatoslava Khorobroho Str., Kyiv, Ukraine, 03161 Author
  • M. O. Trokoz Yuria-Pharm LLC 19, Sviatoslava Khorobroho Str., Kyiv, Ukraine, 03161 Author
  • S. D. Panashchuk Yuria-Pharm LLC 19, Sviatoslava Khorobroho Str., Kyiv, Ukraine, 03161 Author
  • O. M. Hubar Yuria-Pharm LLC 19, Sviatoslava Khorobroho Str., Kyiv, Ukraine, 03161 Author

DOI:

https://doi.org/10.7124/bc.000ABD

Keywords:

T7 RNA polymerase, immobilization, FGE, pAzF, flow reactor synthesis, IVT, therapeutic RNA

Abstract

Aim. To develop protocol for site-specific introduction of bioorthogonal reaction groups into T7 RNAP while preserving activity of the enzyme. Conclusions. For both systems, the optimized protocols were developed, which allow successful incorporation of the bioorthogonal groups with near-quantitative modification efficacy and practical yields. Due to a greater flexibility of pAzF system for tether group positioning it will be used for immobilization studies.

Downloads

Published

2024-09-10

Issue

Section

Chronicle and Information